DOI QR코드

DOI QR Code

Investigation into the mechanism of action of Moringa oleifera for its anti-asthmatic activity

  • Mehta, Anita (Department of Pharmacology, L.M. College of Pharmacy) ;
  • Agrawal, Babita (Department of Pharmacology, L.M. College of Pharmacy)
  • Published : 2008.03.31

Abstract

In the present investigation, we studied the effect of alcoholic extract of Moringa oleifera (M. oleifera) seed kernels on various experimental models of bronchial asthma. Significant (P < 0. 05) increase in preconvulsion time was observed due to pretreatment with M. oleifera when the guinea pigs were exposed to either acetylcholine (Ach) or histamine aerosol. This bronchodilating effect of M. oleifera was comparable to ketotifen fumarate. Spasmolytic effect of M. oleifera was also observed by dose dependent inhibition of ideal contractions induced by Ach, 5HT, histamine and $BaCl_2$. Alcoholic extract of M. oleifera produced significant dose dependent protection by egg albumin and compound 48/80 induced mast cell degranulation. Pretreatment with alcoholic extract of M. oleifera also decreased carrageenan induced rat paw edema, which was comparable to that of standard diclofenac sodium. Minimum inhibitory concentration for alcoholic extract of M. oleifera was low as compared to cold-water extract and hot water extract when antimicrobial activity was tested against various respiratory pathogens like Escherichia coli (E. coli), Staphylococus aureus (S. aureus) and pseudomonas aeruginosa (P. aeruginosa). Our data suggest that antiasthmatic activity of M. oleifera seed kernels may be due to its bronchodilator, anti-inflammatory, mast cell stabilization and antimicrobial activity.

Keywords

Bronchial asthma;Moringa oleifera;Bronchodilator;Anti-inflammatory;Mast cell stabilization

References

  1. Atal CK. (1980) Chemistry and Pharmacology of Vasicine: A new oxyoxic and abortifacient, RRL, Jammu, India. 1980
  2. Bellanti JA. (1971) Mechanism of Tissue Injury produced by Immunologic Reactions In Immunology, Asian Edn: p. 184, W.B. Saunder Co. Tokyo
  3. Bousquet J, Jeffery PK, Busse WW. (2000) Asthma: From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1749-1745
  4. Caceres A, Cebreva O, Morales O, Miollinedo P, Mendia P. (1991) Pharmacological properties of M. oleifera 1: Preliminary screening for antimicrobial activity. J. Ethnopharmacol. 33, 213-216 https://doi.org/10.1016/0378-8741(91)90078-R
  5. Caceres A, Saravia A, Rizzo S, Zabala L, De-Leon E, Nave F. (1992) Pharmacological properties of M. oleifera 2: Screening for antispasmodic, aniinflammatory and diuretic activity. J. Ethnopharmacol. 36, 233-237 https://doi.org/10.1016/0378-8741(92)90049-W
  6. Cockcroft DW. (1983) Mechanism of perennial allergic asthma. Lancet 2, 253-256 https://doi.org/10.1016/S0140-6736(83)90235-0
  7. Cushing JE, Campbell DH. (1957) Manifestations of Antigen Antibody Reactions In Principals of Immunology. p. 278, McGrew-Hill Book Co. Inc. NY
  8. Geetha VS, Viswanathan S, Kameswaran L. (1981) Comparison of total alkaloids of Tylophora indica and disodium cromoglycate on mast cell stabilization. Indian J. Pharm. 13, 199-201
  9. Goyal RK, Patel NJ. (2003) Pharmacovigilance for respiratory disorders in N. Gujarat. In: Pharmacovigilance: an update. p. 190-201
  10. Haalboom JRE, Deenstra A, Stuyvenberg A. (1985) Hypokalaemia induced by inhalation of Fenoterol. Lancet 1, 1125-1127 https://doi.org/10.1016/S0140-6736(85)92432-8
  11. Haranath PSRK, Shyamalakumari S. (1975) Experimental study on the mode of action of Tylophora asthmatica in bronchial asthma. Indian J. Med. Res. 63, 661-670
  12. Harris JM, Spencer PSJ. (1962) A modified plethysmographic apparatus for recording volume changes in rat paw. J. Pharm. Pharmacol. 14, 464-466
  13. Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A, Formisano S. (1987) Inhibition of IgE mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem. Pharmacol. 36, 13-20 https://doi.org/10.1016/0006-2952(87)90377-7
  14. Nasser SS, Rees PJ. (1993) Theophylline. Current thoughts on the risk and benefits of its use in asthma. Drug Saf. 8, 12-18
  15. Sheth UK, Dadkar NK, Kamat NG. (1972) Selected topics in experimental pharmacology. Kohari book depot. Bombay. 5, 63
  16. Singh S, Agrawal SS. (1991) Anti asthmatic and antiinflammatory activity of Ocimum sanctum. Indian J. Pharmacol. 29, 306-310
  17. Tripathi RM, Das PK. (1977) Studies on anti-asthmatic and anti-anaphylactic activity of Albizzia lebbeck. Indian J. Pharmacol. 9, 189-194
  18. Warrier PK, Nambiar VPK, Ramankutty C. (1997) Compendium of Indian medicinal plants. 4, 59
  19. Cox JSG, Beach JE, Blair AM, Clarke AJ, King J, Lee TB. (1970) Disodium chromoglycate (Intal). Adv. Drug Res. 5, 115-196
  20. Dajani BM, Sliman NA, Shubair KS, Hamzeh YS. (1981) Bronchospasm caused by intravenous hydrocortisone sodium succinate (Solu-Cortef') in asprin-sensitive asthmatics. J. Allergy Clin. Immunol. 68, 201-206 https://doi.org/10.1016/0091-6749(81)90184-6
  21. Kirtikar KR, Basu BD. (1975) Indian medicinal plants. (M/s Bishen Singh, Mahendra Pal Singh, New Cannaught Place, Dehradun). Vol. 1, Ed. 2, 676-683
  22. Nelson HS. (1986) Adrenergic therapy of bronchial asthma. J. Allergy Clin. Immunol. 77, 771-785 https://doi.org/10.1016/0091-6749(86)90372-6
  23. Stoloff SW. (1994) The changing role of theophylline in pediatric asthma. Am. Fam. Physician 49, 839-844
  24. Tripathi RM, Sen PC, Das PK. (1979) Studies on the mechanism of action of Albizzia lebbeck, an Indian indigenous drug used in the treatment of atopic allergy. J. Ethnopharmacol. 1, 385-396

Cited by

  1. Evaluation of Cytotoxic and Anti-Inflammatory Activities of Extracts and Lectins from Moringa oleifera Seeds vol.8, pp.12, 2013, https://doi.org/10.1371/journal.pone.0081973
  2. Phytochemistry and Pharmacology of Moringa oleifera Lam vol.20, pp.3, 2017, https://doi.org/10.3831/KPI.2017.20.022
  3. Antioxidant activity of Moringa oleifera seed extracts vol.18, pp.4, 2018, https://doi.org/10.1007/s13596-018-0333-y